Skip to main content
Clinical Trials/IRCT20220603055066N1
IRCT20220603055066N1
Recruiting
未知

Comparative evaluation of PRP (Platelet-Rich Plasma) with nutritional supplements in improvement of hair loss (telogen effluvium) in patients recovered from COVID-19 in Bam Pasteur hospital in 2022

Bam University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
telogen effluvium.
Sponsor
Bam University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bam University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 20 to 50 years
  • Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment
  • Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a pattern similar to telogen effluvium

Exclusion Criteria

  • People who are diagnosed as the other types of alopecia (except telogen effluvium)
  • Pregnant or lactating women
  • Patients who are being treated with drugs such as finasteride, spironolactone, minoxidil or OCP or who have recently stopped taking these drugs
  • Patients who have an underlying disease affecting hair loss
  • Lack of informed consent to enter the study

Outcomes

Primary Outcomes

Not specified

Similar Trials